Early mucocutaneous congenital syphilis
ICD-10 A50.07 is a billable code used to indicate a diagnosis of early mucocutaneous congenital syphilis.
Early mucocutaneous congenital syphilis refers to the manifestation of syphilis in newborns that occurs when the infection is transmitted from an infected mother during pregnancy. This condition typically presents within the first two years of life and is characterized by mucocutaneous lesions, which may include rashes, mucosal lesions, and other systemic signs. The lesions can appear on the skin, mouth, and other mucous membranes, and may be accompanied by other symptoms such as fever, irritability, and failure to thrive. Early diagnosis and treatment are crucial to prevent long-term complications, including skeletal deformities and neurological issues. The diagnosis is confirmed through serological testing and clinical evaluation. Treatment usually involves the administration of penicillin, which is effective in eradicating the infection. Close monitoring and follow-up are essential to ensure the resolution of symptoms and to assess for any potential complications.
Detailed clinical notes on the infant's symptoms, maternal history, and treatment response.
Infants presenting with rashes, mucosal lesions, or systemic symptoms shortly after birth.
Documentation must clearly indicate the timing of maternal infection and any treatment provided.
Comprehensive prenatal records, including syphilis screening results and treatment history.
Pregnant women with a history of syphilis or positive serology requiring monitoring and treatment.
Ensure that maternal treatment is documented to support the diagnosis of congenital syphilis.
Used to confirm diagnosis of congenital syphilis in infants.
Document the reason for testing and results.
Pediatricians should ensure maternal history is included.
Key symptoms include rashes, mucosal lesions, fever, irritability, and failure to thrive, typically presenting within the first two years of life.
